In This Article:
Robust, high-growth companies such as Factor Therapeutics are appealing to investors for many reasons. They bring about a strong upside to your portfolio, and less downside risk as opposed to financially challenged companies. If your holdings could benefit from diversification towards growth stocks, whether it be in reputable tech stocks or green small-caps, take a look at my list of stocks with a bright future ahead.
Factor Therapeutics Limited (ASX:FTT)
Factor Therapeutics Limited, a clinical stage biotechnology company, develops and commercializes treatments for wound care and healing in Australia and Europe. Factor Therapeutics is currently run by Rosalind Wilson. It currently has a market cap of AUD A$27.74M placing it in the small-cap group
FTT’s forecasted bottom line growth is an exceptional triple-digit, driven by underlying sales, which is expected to more than double, over the next few years. It appears that FTT’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. We see this bottom-line expansion directly benefiting shareholders, with expected positive return on equity of 18.46%. FTT’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. A potential addition to your portfolio? Have a browse through its key fundamentals here.
Paringa Resources Limited (ASX:PNL)
Paringa Resources Limited, together with its subsidiaries, engages in the exploration and development of resource projects. Paringa Resources was established in 2012 and has a market cap of AUD A$115.68M, putting it in the small-cap group.
Extreme optimism for PNL, as market analysts projected an outstanding earnings growth rate of 54.68% for the stock, supported by an equally strong sales. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected positive return on equity of 15.64%. PNL ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. A potential addition to your portfolio? I recommend researching its fundamentals here.
Infomedia Ltd. (ASX:IFM)
Infomedia Ltd., a technology company, develops and supplies electronic parts catalogues and service quoting software systems for the automotive industry in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Started in 1987, and currently lead by Jonathan Rubinsztein, the company employs 250 people and with the company’s market capitalisation at AUD A$257.29M, we can put it in the small-cap group.